Ok so here’s some blurbs from CNN Business website and more...
The 4 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +105.99% increase from the last price of 2.67.
The current consensus among 4 polled investment analysts is to buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a buy rating.
Market Data 
Markets 
AI
